{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:16:35Z","timestamp":1791965795052,"version":"4.3.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T00:00:00Z","timestamp":1675641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T00:00:00Z","timestamp":1675641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s10072-023-06617-y","type":"journal-article","created":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T07:03:05Z","timestamp":1675666985000},"page":"1905-1915","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Worldwide prevalence of neuromyelitis optica spectrum disorder (NMOSD) and neuromyelitis optica (NMO): a systematic review and meta-analysis"],"prefix":"10.1007","volume":"44","author":[{"given":"Sara","family":"Bagherieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Afshari-Safavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Vaheb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Kiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham Moases","family":"Ghaffary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Barzegar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Shaygannejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aram","family":"Zabeti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3756-2985","authenticated-orcid":false,"given":"Omid","family":"Mirmosayyeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,6]]},"reference":[{"key":"6617_CR1","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1177\/1352458515572406","volume":"21","author":"L Pandit","year":"2015","unstructured":"Pandit L, Asgari N, Apiwattanakul M et al (2015) Demographic and clinical features of neuromyelitis optica: a review. Mult Scler 21:845\u2013853","journal-title":"Mult Scler"},{"key":"6617_CR2","doi-asserted-by":"publisher","first-page":"470","DOI":"10.4103\/0028-3886.103186","volume":"60","author":"L Pandit","year":"2012","unstructured":"Pandit L, Shetty R, Misri Z et al (2012) Optic neuritis: experience from a south Indian demyelinating disease registry. Neurol India 60:470\u2013475","journal-title":"Neurol India"},{"key":"6617_CR3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/1352458517737371","volume":"24","author":"V Papp","year":"2018","unstructured":"Papp V, Iljicsov A, Rajda C et al (2018) The Hungarian population-based prevalence and incidence study of neuromyelitis optica spectrum disorder. Mult Scler J 24:75\u201376","journal-title":"Mult Scler J"},{"key":"6617_CR4","doi-asserted-by":"publisher","first-page":"e2265","DOI":"10.1212\/WNL.0000000000006645","volume":"91","author":"V Papp","year":"2018","unstructured":"Papp V, Illes Z, Magyari M et al (2018) Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark. Neurology 91:e2265\u2013e2275","journal-title":"Neurology"},{"key":"6617_CR5","first-page":"S63","volume":"17","author":"MS Park","year":"2011","unstructured":"Park MS, Kim MK, Kim BJ et al (2011) Benign course in neuromyelitis optica. Mult Scler 17:S63\u2013S64","journal-title":"Mult Scler"},{"key":"6617_CR6","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jns.2014.12.031","volume":"349","author":"J-t Peng","year":"2015","unstructured":"Peng J-t, Cong H-r, Yan R et al (2015) Neurological outcome and predictive factors of idiopathic optic neuritis in China. J Neurol Sci 349:94\u201398","journal-title":"J Neurol Sci"},{"key":"6617_CR7","first-page":"S101","volume":"258","author":"M Radaelli","year":"2011","unstructured":"Radaelli M, Martinelli V, Moiola L, Da P (2011) Neuromyelitis optica spectrum disorder: the importance of NMO-IgG in clinical practice. J Neurol 258:S101","journal-title":"J Neurol"},{"key":"6617_CR8","doi-asserted-by":"crossref","unstructured":"Rezaeimanesh N, Sahraian MA, Moghadasi AN, Eskandarieh S (2020) Epidemiology of neuromyelitis optica spectrum disorder in Tehran. Iran: the prevalence, baseline characteristics, and clinical aspects:2647\u20132648","DOI":"10.1007\/s10072-020-04393-7"},{"key":"6617_CR9","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/ICU.0000000000000703","volume":"31","author":"KB Holroyd","year":"2020","unstructured":"Holroyd KB, Manzano GS, Levy M (2020) Update on neuromyelitis optica spectrum disorder. Curr Opin Ophthalmol 31:462\u2013468","journal-title":"Curr Opin Ophthalmol"},{"key":"6617_CR10","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1212\/WNL.0000000000008325","volume":"93","author":"N Asgari","year":"2019","unstructured":"Asgari N, Flanagan EP (2019) Reader response: nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark. Neurology 93:722\u2013723","journal-title":"Neurology"},{"key":"6617_CR11","volume":"2015","author":"M Etemadifar","year":"2015","unstructured":"Etemadifar M, Nasr Z, Khalili B, Taherioun M, Vosoughi R (2015) Epidemiology of neuromyelitis optica in the world: a systematic review and meta-analysis. Mult Scler Int 2015:174720","journal-title":"Mult Scler Int"},{"key":"6617_CR12","doi-asserted-by":"publisher","first-page":"113","DOI":"10.7224\/1537-2073.2012-048","volume":"15","author":"RA Marrie","year":"2013","unstructured":"Marrie RA, Gryba C (2013) The incidence and prevalence of neuromyelitis optica: a systematic review. Int J MS Care 15:113\u2013118","journal-title":"Int J MS Care"},{"key":"6617_CR13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1212\/WNL.0000000000011153","volume":"96","author":"V Papp","year":"2021","unstructured":"Papp V, Magyari M, Aktas O et al (2021) Worldwide incidence and prevalence of neuromyelitis optica. Neurology 96:59","journal-title":"Neurology"},{"key":"6617_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603\u2013605","journal-title":"Eur J Epidemiol"},{"key":"6617_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079649","volume":"8","author":"F Aboul-Enein","year":"2013","unstructured":"Aboul-Enein F, Seifert-Held T, Mader S et al (2013) Neuromyelitis optica in Austria in 2011: to bridge the gap between neuroepidemiological research and practice in a study population of 8.4 million people. PloS one 8:e79649","journal-title":"PloS one"},{"key":"6617_CR16","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1177\/1352458516643399","volume":"22","author":"LJ Cook","year":"2016","unstructured":"Cook LJ, Rose JW, Alvey J et al (2016) A comparison of seropositive and seronegative patients in the Collaborative International Research in Clinical and Longitudinal Experience for NMOSD Studies (CIRCLES) registry. Mult Scler 22:852\u2013853","journal-title":"Mult Scler"},{"key":"6617_CR17","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1212\/WNL.0b013e3182190f74","volume":"76","author":"N Asgari","year":"2011","unstructured":"Asgari N, Lillevang ST, Skejoe HPB, Falah M, Stenager E, Kyvik KO (2011) A population-based study of neuromyelitis optica in Caucasians. Neurology 76:1589\u20131595","journal-title":"Neurology"},{"key":"6617_CR18","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.neurol.2009.02.012","volume":"165","author":"P Cabre","year":"2009","unstructured":"Cabre P, Gonzalez-Quevedo A, Lannuzel A et al (2009) Descriptive epidemiology of neuromyelitis optica in the Caribbean basin. Rev Neurol 165:676\u2013683","journal-title":"Rev Neurol"},{"key":"6617_CR19","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1212\/WNL.56.4.507","volume":"56","author":"P Cabre","year":"2001","unstructured":"Cabre P, Heinzlef O, Merle H et al (2001) MS and neuromyelitis optica in Martinique (French West Indies). Neurology 56:507\u2013514","journal-title":"Neurology"},{"key":"6617_CR20","first-page":"175","volume":"13","author":"P Lekha","year":"2008","unstructured":"Lekha P (2008) Neuromyelitis optica antibody (NMO-IgG) status in Indian patients with multiple sclerosis and allied demyelinating disorders. Neurology Asia 13:175\u2013178","journal-title":"Neurology Asia"},{"key":"6617_CR21","first-page":"204","volume":"14","author":"D Kashipazha","year":"2015","unstructured":"Kashipazha D, Mohammadianinejad SE, Majdinasab N, Azizi M, Jafari M (2015) A descriptive study of prevalence, clinical features and other findings of neuromyelitis optica and neuromyelitis optica spectrum disorder in Khuzestan Province. Iran J Neurol 14:204\u2013210","journal-title":"Iran J Neurol"},{"key":"6617_CR22","doi-asserted-by":"crossref","unstructured":"Etemadifar M, Dashti M, Vosoughi R, Abtahi SH, Ramagopalan SV, Nasr Z (2014) An epidemiological study of neuromyelitis optica in Isfahan. Mult Scler:1920\u20131922","DOI":"10.1177\/1352458514537699"},{"key":"6617_CR23","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1212\/WNL.0000000000004611","volume":"89","author":"H Houzen","year":"2017","unstructured":"Houzen H, Kondo K, Niino M et al (2017) Prevalence and clinical features of neuromyelitis optica spectrum disorders in northern Japan. Neurology 89:1995\u20132001","journal-title":"Neurology"},{"key":"6617_CR24","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1007\/s00415-008-0781-2","volume":"255","author":"JF Rivera","year":"2008","unstructured":"Rivera JF, Kurtzke JF, Booth VJ (2008) Characteristics of Devic\u2019s disease (neuromyelitis optica) in Mexico. J Neurol 255:710\u2013715","journal-title":"J Neurol"},{"key":"6617_CR25","doi-asserted-by":"publisher","first-page":"e181","DOI":"10.1212\/WNL.0000000000007746","volume":"93","author":"DI Jonsson","year":"2019","unstructured":"Jonsson DI, Sveinsson O, Hakim R, Brundin L (2019) Epidemiology of NMOSD in Sweden from 1987 to 2013: a nationwide population-based study. Neurology 93:e181\u2013e189","journal-title":"Neurology"},{"key":"6617_CR26","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1007\/s00415-013-6926-y","volume":"260","author":"A Jacob","year":"2013","unstructured":"Jacob A, Panicker J, Lythgoe D et al (2013) The epidemiology of neuromyelitis optica amongst adults in the Merseyside county of United Kingdom. J Neurol 260:2134\u20132137","journal-title":"J Neurol"},{"key":"6617_CR27","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/j.1468-1331.2011.03529.x","volume":"19","author":"M Cossburn","year":"2012","unstructured":"Cossburn M, Tackley G, Baker K et al (2012) The prevalence of neuromyelitis optica in South East Wales. Eur J Neurol 19:655\u2013659","journal-title":"Eur J Neurol"},{"key":"6617_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00415-009-0009-0","volume":"256","author":"JA Cabrera-Gmez","year":"2009","unstructured":"Cabrera-Gmez JA, Kurtzke JF, Gonzlez-Quevedo A, Lara-Rodrguez R (2009) An epidemiological study of neuromyelitis optica in Cuba. J Neurol 256:35\u201344","journal-title":"J Neurol"},{"key":"6617_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102425","volume":"45","author":"C-W Fang","year":"2020","unstructured":"Fang C-W, Wang H-P, Chen H-M, Lin J-W, Lin W-S (2020) Epidemiology and comorbidities of adult multiple sclerosis and neuromyelitis optica in Taiwan, 2001-2015. Mult Scler Relat Disord 45:102425","journal-title":"Mult Scler Relat Disord"},{"key":"6617_CR30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1742-2094-9-14","volume":"9","author":"S Jarius","year":"2012","unstructured":"Jarius S, Ruprecht K, Wildemann B et al (2012) Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients. J Neuroinflammation 9:14","journal-title":"J Neuroinflammation"},{"key":"6617_CR31","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.neurol.2019.08.009","volume":"176","author":"S Mejdoub","year":"2020","unstructured":"Mejdoub S, Feki S, Dammak M et al (2020) Neuromyelitis optica spectrum disorders in South of Tunisia: a rare entity with low seroprevalence of anti-aquaporin 4 autoantibodies. Rev Neurol 176:261\u2013267","journal-title":"Rev Neurol"},{"key":"6617_CR32","doi-asserted-by":"crossref","unstructured":"Absoud M, Lim MJ, Appleton R et al (2015) Paediatric neuromyelitis optica: clinical. MRI of the brain and prognostic features:470\u2013472","DOI":"10.1136\/jnnp-2014-308550"},{"key":"6617_CR33","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1136\/jnnp-2016-314839","volume":"88","author":"W Bukhari","year":"2017","unstructured":"Bukhari W, Prain KM, Waters P et al (2017) Incidence and prevalence of NMOSD in Australia and New Zealand. J Neurol Neurosurg Psychiatry 88:632\u2013638","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6617_CR34","unstructured":"Bukhari W, Khalilidehkordi E, Mason DF et al (2021) NMOSD and MS prevalence in the Indigenous populations of Australia and New Zealand. J Neurol"},{"key":"6617_CR35","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jneuroim.2018.02.003","volume":"318","author":"MA Lana-Peixoto","year":"2018","unstructured":"Lana-Peixoto MA, Pedrosa D, Talim N, Amaral JMSS, Horta A, Kleinpaul R (2018) Neuromyelitis optica spectrum disorder associated with dengue virus infection. J Neuroimmunol 318:53\u201355","journal-title":"J Neuroimmunol"},{"key":"6617_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.102807","volume":"50","author":"MA Lana-Peixoto","year":"2021","unstructured":"Lana-Peixoto MA, Talim NC, Pedrosa D, Macedo JM, Santiago-Amaral J (2021) Prevalence of neuromyelitis optica spectrum disorder in Belo Horizonte, Southeast Brazil. Mult Scler Relat Disord 50:102807","journal-title":"Mult Scler Relat Disord"},{"key":"6617_CR37","doi-asserted-by":"crossref","unstructured":"Tian D-C, Li Z, Yuan M et al (2021) Incidence of neuromyelitis optica spectrum disorder (NMOSD) in China: a national population-based study (vol 2, 100021, 2020). Lancet Regional Health-Western Pacific 8","DOI":"10.1016\/j.lanwpc.2020.100021"},{"key":"6617_CR38","doi-asserted-by":"crossref","unstructured":"Papp V, Illes Z, Magyari M et al The Danish National Epidemiology of Neuromyelitis Optica Spectrum Disorders Based On the 2015 International Panel for NMO Diagnosis (IPND) Criteria. Neurology 2018:90","DOI":"10.1212\/WNL.90.15_supplement.P1.138"},{"key":"6617_CR39","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/ene.14079","volume":"27","author":"V Papp","year":"2020","unstructured":"Papp V, Iljicsov A, Rajda C et al (2020) A population-based epidemiological study of neuromyelitis optica spectrum disorder in Hungary. Eur J Neurol 27:308\u2013317","journal-title":"Eur J Neurol"},{"key":"6617_CR40","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/ene.14079","volume":"27","author":"V Papp","year":"2020","unstructured":"Papp V, Magyari M, Koch-Henriksen NJ et al (2020) Population-based comparative studies of the epidemiology of neuromyelitis optica spectrum disorder (NMOSD) in Europe. Eur J Neurol 27:461\u2013462","journal-title":"Eur J Neurol"},{"key":"6617_CR41","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.msard.2017.01.004","volume":"12","author":"S Eskandarieh","year":"2017","unstructured":"Eskandarieh S, Nedjat S, Abdollahpour I, Moghadasi AN, Azimi AR, Sahraian MA (2017) Comparing epidemiology and baseline characteristic of multiple sclerosis and neuromyelitis optica: a case-control study. Mult Scler Relat Disord 12:39\u201343","journal-title":"Mult Scler Relat Disord"},{"key":"6617_CR42","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.msard.2017.10.007","volume":"18","author":"S Eskandarieh","year":"2017","unstructured":"Eskandarieh S, Nedjat S, Azimi AR, Moghadasi AN, Sahraian MA (2017) Neuromyelitis optica spectrum disorders in Iran. Mult Scler Relat Disord 18:209\u2013212","journal-title":"Mult Scler Relat Disord"},{"key":"6617_CR43","first-page":"NP15","volume":"24","author":"S Eskandarieh","year":"2018","unstructured":"Eskandarieh S, Nedjat S, Azimi AR, Moghadasi AN, Sahraian MA (2018) The prevalence and characteristics of neuromyelitis optica spectrum disorder in Tehran. Iran Multiple Sclerosis Journal 24:NP15\u2013NP16","journal-title":"Iran Multiple Sclerosis Journal"},{"key":"6617_CR44","unstructured":"Seplveda M, Armangu. (2016) Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus. Neuro:3"},{"key":"6617_CR45","unstructured":"Szilasiov. (2021) Incidence and prevalence of neuromyelitis optica spectrum disorders in Slovakia. Neurol Res"},{"key":"6617_CR46","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/ncn3.12478","volume":"9","author":"JY Hor","year":"2021","unstructured":"Hor JY, Wong CK, Ew JV, Idris S, Tan HJ, Wong DYJ (2021) Neuromyelitis optica spectrum disorder in Asia: epidemiology and risk factors. Neurol Clin Neurosci 9:274\u2013281","journal-title":"Neurol Clin Neurosci"},{"key":"6617_CR47","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1177\/1352458518792430","volume":"25","author":"S Viswanathan","year":"2019","unstructured":"Viswanathan S, Wah LM (2019) A nationwide epidemiological study on the prevalence of multiple sclerosis and neuromyelitis optica spectrum disorder with important multi-ethnic differences in Malaysia. Multiple sclerosis 25:1452\u20131461","journal-title":"Multiple sclerosis"},{"key":"6617_CR48","doi-asserted-by":"crossref","unstructured":"Miyamoto K, Fujihara K, Kira J-I et al (2018) Nationwide epidemiological study of neuromyelitis optica in Japan:667\u2013668","DOI":"10.1136\/jnnp-2017-317321"},{"key":"6617_CR49","doi-asserted-by":"crossref","unstructured":"Dale GHa. Response to Epidemiology of neuromyelitis optica spectrum disorder\u201d. 2018: 628\u2013629","DOI":"10.1111\/ane.12937"},{"key":"6617_CR50","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.jns.2017.08.2222","volume":"381","author":"K Miyamoto","year":"2017","unstructured":"Miyamoto K, Fujihara K, Kira JI et al (2017) The prevalence and characteristics of neuromyelitis optica in Japan: a nationwide epidemiological study. J Neurol Sci 381:787","journal-title":"J Neurol Sci"},{"key":"6617_CR51","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1177\/1352458518761187","volume":"25","author":"J Kim","year":"2019","unstructured":"Kim J, Seok JM, Lee HJ, Kim BJ, Min JH (2019) Epidemiology of multiple sclerosis and neuromyelitis optica spectrum disorder in South Korea. Mult Scler J 25:610","journal-title":"Mult Scler J"},{"key":"6617_CR52","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.msard.2018.10.023","volume":"26","author":"B Aa","year":"2018","unstructured":"Aa B (2018) Characteristics of neuromyelitis optica spectrum disorder in a Moroccan population. Mult Scler Relat Disord 26:235","journal-title":"Mult Scler Relat Disord"},{"key":"6617_CR53","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85:177\u2013189","journal-title":"Neurology"},{"key":"6617_CR54","doi-asserted-by":"crossref","unstructured":"Tian D-C, Li Z, Yuan M et al (2020) Incidence of neuromyelitis optica spectrum disorder (NMOSD) in China: a national population-based study. Lancet Regional Health-Western Pacific:2","DOI":"10.1016\/j.lanwpc.2020.100021"},{"key":"6617_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2020.100039","volume":"3","author":"S Viswanathan","year":"2020","unstructured":"Viswanathan S (2020) Regional and global perspectives on the incidence of multiple sclerosis and neuromyelitis optica and its spectrum disorders from Asia with emphasis on China. The Lancet regional health Western Pacific 3:100039","journal-title":"The Lancet regional health Western Pacific"},{"key":"6617_CR56","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.msard.2018.07.003","volume":"25","author":"S Viswanathan","year":"2018","unstructured":"Viswanathan S, Rose N, Arip M et al (2018) Multiple sclerosis and neuromyelitis optica spectrum disorders in Malaysia: a comparison in different ethnic groups. Mult Scler Relat Disord 25:300\u2013308","journal-title":"Mult Scler Relat Disord"},{"key":"6617_CR57","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1007\/s00415-014-7298-7","volume":"261","author":"Y Wang","year":"2014","unstructured":"Wang Y, Zhang L, Zhang B et al (2014) Comparative clinical characteristics of neuromyelitis optica spectrum disorders with and without medulla oblongata lesions. J Neurol 261:954\u2013962","journal-title":"J Neurol"},{"key":"6617_CR58","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.msard.2016.06.006","volume":"9","author":"T Tengsirikomol","year":"2016","unstructured":"Tengsirikomol T, Siritho S, Prayoonwiwat N (2016) How long does it take to diagnose patients with neuromyelitis optica (NMO) using the 2006 diagnostic criteria? Mult Scler Relat Disord 9:14\u201316","journal-title":"Mult Scler Relat Disord"},{"key":"6617_CR59","first-page":"NP73","volume":"26","author":"C Yanyu","year":"2020","unstructured":"Yanyu C (2020) Familial neuromyelitis optica spectrum disorder in Chinese population: a clinical profile and whole exome sequencing study. Mult Scler J 26:NP73","journal-title":"Mult Scler J"},{"key":"6617_CR60","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1179\/1743132815Y.0000000081","volume":"37","author":"J Yin","year":"2015","unstructured":"Yin J, Long Y, Shan F et al (2015) Clinical manifestations of neuromyelitis optica in male and female patients. Neurol Res 37:967\u2013973","journal-title":"Neurol Res"},{"key":"6617_CR61","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1055\/s-0043-108909","volume":"45","author":"S Thiel","year":"2018","unstructured":"Thiel S, Leypoldt F, Roepke L et al (2018) Neuroimmunological Registries in Germany Aktuelle Neurologie 45:7\u201323","journal-title":"Neuroimmunological Registries in Germany Aktuelle Neurologie"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-06617-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-023-06617-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-06617-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,13]],"date-time":"2024-10-13T17:05:13Z","timestamp":1728839113000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-023-06617-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,6]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["6617"],"URL":"https:\/\/doi.org\/10.1007\/s10072-023-06617-y","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,6]]},"assertion":[{"value":"6 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}